𝔖 Bobbio Scriptorium
✦   LIBER   ✦

73 P - Oral idarubicin (OIDA) in elderly patients (pts) with acute myelogenous Leukemia (AML): An opportunity?

✍ Scribed by F.C.A. Visentin; F. Ganzina; I. Smeets; M. Biggi

Book ID
116168348
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
180 KB
Volume
32
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clofarabine in combination with a standa
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)
✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr πŸ“‚ Article πŸ“… 2014 πŸ› Springer 🌐 English βš– 197 KB